147 related articles for article (PubMed ID: 2326751)
1. Effects of phorone and/or buthionine sulfoximine on teratogenicity of 5-fluorouracil in mice.
Naya M; Mataki Y; Takahira H; Deguchi T; Yasuda M
Teratology; 1990 Mar; 41(3):275-80. PubMed ID: 2326751
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of murine phenytoin teratogenicity by the gamma-glutamylcysteine synthetase inhibitor L-buthionine-(S,R)-sulfoximine and by the glutathione depletor diethyl maleate.
Wong M; Helston LM; Wells PG
Teratology; 1989 Aug; 40(2):127-41. PubMed ID: 2772848
[TBL] [Abstract][Full Text] [Related]
3. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
4. Effects of L-2-oxothiazolidine-4-carboxylate, a cysteine pro-drug, on teratogenicity of 5-fluorouracil in mice.
Naya M; Noguchi M; Mataki Y; Deguchi T; Yasuda M
Hiroshima J Med Sci; 1990 Sep; 39(3):79-82. PubMed ID: 2283306
[TBL] [Abstract][Full Text] [Related]
5. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
Kramer RA; Greene K; Ahmad S; Vistica DT
Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
[TBL] [Abstract][Full Text] [Related]
7. Effect of the glutathione-depleting agents diethylmaleate, phorone and buthionine sulfoximine on biliary copper excretion in rats.
Nederbragt H
Biochem Pharmacol; 1989 Oct; 38(20):3399-406. PubMed ID: 2818632
[TBL] [Abstract][Full Text] [Related]
8. The role of glutathione in lymphocyte activation. I. Comparison of inhibitory effects of buthionine sulfoximine and 2-cyclohexene-1-one by nuclear size transformation.
Hamilos DL; Wedner HJ
J Immunol; 1985 Oct; 135(4):2740-7. PubMed ID: 4031498
[TBL] [Abstract][Full Text] [Related]
9. Metabolic changes in glutathione and metallothionein in newborn rat liver.
Gallant KR; Cherian MG
J Pharmacol Exp Ther; 1989 May; 249(2):631-7. PubMed ID: 2566683
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
[TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
Kang YJ
Cell Mol Biol Res; 1995; 41(2):131-6. PubMed ID: 8581064
[TBL] [Abstract][Full Text] [Related]
12. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
Bertsche U; Schorn H
Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
[TBL] [Abstract][Full Text] [Related]
13. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
14. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
Miller AC; Henderson BW
J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
[TBL] [Abstract][Full Text] [Related]
15. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts.
Guichard M; Lespinasse F; Malaise EP
Radiat Res; 1986 Jan; 105(1):115-25. PubMed ID: 3945723
[TBL] [Abstract][Full Text] [Related]
16. The effect of in vivo glutathione depletion with buthionine sulfoximine on rat embryo development.
Hales BF; Brown H
Teratology; 1991 Sep; 44(3):251-7. PubMed ID: 1948763
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
18. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
19. 5-Fluorouracil cytotoxicity in human colon HT-29 cells with moderately increased or decreased cellular glutathione level.
Chen MF; Chen LT; Boyce HW
Anticancer Res; 1995; 15(1):163-7. PubMed ID: 7733628
[TBL] [Abstract][Full Text] [Related]
20. Anti-hypoxic effect of glutathione depletors.
Masukawa T; Sai M; Tochino Y
Life Sci; 1989; 44(5):311-8. PubMed ID: 2915602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
